Pre hearing information
The tribunal will inquire into the allegation that between January 2013 and July 2017 Dr Qureshi practised as a consultant ophthalmologist at the London Eye Hospital and during the same period he was the sole director and shareholder of London Eye Hospital Limited (‘LEH Ltd’). It is also alleged that Dr Qureshi was the patent holder of the IOL-AMD lens and the ‘Eyemax Mono’ lens.
It is also alleged that on or around 19 July 2015 Dr Qureshi caused to be published an advertisement for the IOL-AMD procedure in the national press which was unsubstantiated and that he knew was unsubstantiated. It is alleged that in publishing the advertisement Dr Qureshi’s conduct was dishonest.
It is further alleged, that a number of concerns have been raised about Dr Qureshi’s clinical practice relating to his treatment of multiple patients, patients A to X.
The above reflects the allegation as it stands at the start of the hearing. The allegation may be amended as the hearing proceeds and when findings of fact are made by the tribunal.
This reflects the allegation as it stands at the start of the hearing. The allegation may be amended as the hearing proceeds and when findings of fact are made by the tribunal.
All decisions are published online within 28 days of the conclusion of the hearing.
If you're a journalist and need up to date information about the allegation throughout the course of the hearing, please contact our press office at firstname.lastname@example.org or call 0161 250 6868.
In accordance with Rule 41(2) of the General Medical Council (Fitness to Practise) Rules 2004, the tribunal may decide to exclude the public from the proceedings or any part of the proceedings, where they consider that the circumstances of the case outweigh the public interest in holding the hearing in public.